Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
about
Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review.Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection.Novel Chimeric Protein Vaccines Against Infection
P2860
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Extended-pulsed fidaxomicin ve ...... open-label, phase 3b/4 trial.
@en
Extended-pulsed fidaxomicin ve ...... open-label, phase 3b/4 trial.
@nl
type
label
Extended-pulsed fidaxomicin ve ...... open-label, phase 3b/4 trial.
@en
Extended-pulsed fidaxomicin ve ...... open-label, phase 3b/4 trial.
@nl
prefLabel
Extended-pulsed fidaxomicin ve ...... open-label, phase 3b/4 trial.
@en
Extended-pulsed fidaxomicin ve ...... open-label, phase 3b/4 trial.
@nl
P2093
P50
P1476
Extended-pulsed fidaxomicin ve ...... open-label, phase 3b/4 trial.
@en
P2093
Andreas Karas
Areti Georgopali
Benoit Guery
EXTEND Clinical Study Group
Francesco Menichetti
Gbenga Kazeem
Jose Alejandro Palacios-Fabrega
Jose Maria Aguado
Karen Bisnauthsing
Maria J G T Vehreschild
P304
P356
10.1016/S1473-3099(17)30751-X
P577
2017-12-19T00:00:00Z